tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 25 are a BUY (51.02%), 11 are a HOLD (22.45%), 13 are a SELL (26.53%).
Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 56.67% that have a potential upside of 43.47% achieved within 205 days.
Alec Stranahan’s has documented 97 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KRYS, Krystal Biotech at 22-Jan-2026.
Analyst best performing recommendations are on BTAI (BIOXCEL THERAPEUTICS).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/20/2022. The price target of $5 was fulfilled within 4 days with a profit of $0.39 (7.24%) receiving and performance score of 18.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jun-2019
$15
$5.01 (50.15%)
$13
8 months 7 days ago
(15-Jul-2025)
8/9 (88.89%)
$10.24 (215.13%)
298
Buy Since 08-Aug-2023
$36
8 months 21 days ago
(01-Jul-2025)
0/3 (0%)
$28.31 (368.14%)
Buy Since 05-Nov-2021
$4
$-5.99 (-59.96%)
$72
1 years 7 months 20 days ago
(02-Aug-2024)
1/4 (25%)
$-15.2 (-79.17%)
249
Hold Since 04-Nov-2022
$16
3 years 4 months 18 days ago
(04-Nov-2022)
1/3 (33.33%)
$-43.04 (-72.90%)
273
Buy Since 13-Jan-2020
$15
$5.01 (50.15%)
$228
3 years 6 months 27 days ago
(23-Aug-2022)
2/4 (50%)
$-38.28 (-71.85%)
152
Which stock is Alec Stranahan is most bullish on?
What Year was the first public recommendation made by Alec Stranahan?
